JBT Marel (JBTM)
NYSE:JBTM
Top Page
JBT Marel
(NYSE:JBTM)
Select Model
Select Model
Rating:58Neutral
Price Target:
$137.00
▲(6.57% Upside)
Action:ReiteratedDate:03/26/26
The score is driven by improving balance-sheet strength and solid cash generation, but is held back by the sharp 2025 profitability drop and weak technical momentum. Positive 2026 guidance and synergy-driven margin expansion provide an important offset, while valuation support is limited due to a negative P/E and low dividend yield.
Positive Factors
Deleveraged Balance Sheet
Material deleveraging to a ~0.09 debt-to-equity ratio meaningfully reduces financial risk and interest burden, increasing capacity for capital allocation to growth, synergies, and working capital. A stronger capital structure supports resilience through cyclical demand swings and M&A optionality.
Negative Factors
2025 Profitability Deterioration
A sharp decline to a net loss and collapsing EBITDA margin signal weakened earnings quality and potential structural cost pressures. If below-the-line charges or weak cost absorption persist, the company may struggle to convert revenue growth into durable profitability and cash generation.
Read all positive and negative factors
Positive Factors
Negative Factors
Deleveraged Balance Sheet
Material deleveraging to a ~0.09 debt-to-equity ratio meaningfully reduces financial risk and interest burden, increasing capacity for capital allocation to growth, synergies, and working capital. A stronger capital structure supports resilience through cyclical demand swings and M&A optionality.
Read all positive factors
JBT Marel (JBTM) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$6.68B
Dividend Yield0.26%
Average Volume (3M)483.08K
Price to Earnings (P/E)―
Beta (1Y)0.77
Revenue Growth91.98%
EPS Growth-141.14%
CountryUS
Employees11,700
SectorIndustrials
Sector Strength72
IndustryIndustrial - Machinery
Share Statistics
EPS (TTM)1.98
Shares Outstanding51,982,204
10 Day Avg. Volume609,523
30 Day Avg. Volume483,077
Financial Highlights & Ratios
PEG Ratio1.13
Price to Book (P/B)1.76
Price to Sales (P/S)2.06
P/FCF Ratio32.91
Enterprise Value/Market Cap1.25
Enterprise Value/Revenue2.21
Enterprise Value/Gross Profit6.28
Enterprise Value/Ebitda27.75
Forecast
1Y Price Target
$160.00Price Target Upside24.47% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
EPS Forecast (FY)8.21
Revenue Forecast (FY)$4.02B
JBT Marel Business Overview & Revenue Model
Company Description
JBT Marel Corporation provides technology solutions to food and beverage industry in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers value-added processing that includes chilling, mixing/grinding, inj...
How the Company Makes Money
JBTM primarily makes money by selling capital equipment and integrated systems used in food and beverage production, and by earning recurring revenue from aftermarket products and services that keep installed equipment running. Key revenue streams...
JBT Marel Earnings Call Summary
Earnings Call Date:Feb 23, 2026
(Q4-2025)
| % Change Since: |
Next Earnings Date:May 04, 2026
Earnings Call Sentiment Positive
The call conveyed a broadly positive outlook: the combined JBT Marel business delivered better-than-expected revenue, achieved adjusted EPS accretion in year one, realized meaningful synergy and run-rate savings, materially reduced leverage, and provided confident 2026 guidance with meaningful EBITDA and EPS upside. Primary negatives were tariff-driven cost pressure (material in 2025 and expected to increase in early 2026), a Q4 margin dip, and some operational inefficiencies in Prepared Foods/AGV that are expected to be temporary. Taken together, the operational and financial achievements substantially outweigh the near-term macro and tariff headwinds.Positive Updates
Strong Order Intake and Backlog Conversion
Full-year orders of $3.8 billion with more than $1.0 billion in Q4; management noted strong conversion of backlog to revenue and accelerating order synergies (captured $30 million in order synergies for 2025, more than half in Q4) that are expected to convert to revenue in 2026.
Negative Updates
Tariff Headwinds and Cost Impact
Higher tariff environment (since April 2025) cost the company approximately $43 million in 2025 net of $15 million of cost avoidance; tariffs reduced adjusted EBITDA margin by roughly 50 basis points in 2025. Management expects approximately $45 million of higher tariff costs for full-year 2026 (pre-mitigation) and anticipates a net full-year margin headwind in the ~25–50 basis point range depending on pricing and market dynamics.
Read all updates
Q4-2025 Updates
Positive
Negative
Strong Order Intake and Backlog Conversion
Full-year orders of $3.8 billion with more than $1.0 billion in Q4; management noted strong conversion of backlog to revenue and accelerating order synergies (captured $30 million in order synergies for 2025, more than half in Q4) that are expected to convert to revenue in 2026.
Read all positive updates
Company Guidance
The company guided to full-year 2026 consolidated revenue growth of 5%–7% (including ~1% FX tailwind), with adjusted EBITDA margins of 17.0%–17.5% (about +145 bps year-over-year at the midpoint) and adjusted EPS of $8.00–$8.50 (GAAP EPS $4.70–$5.15); management included roughly $45 million of incremental tariff headwinds (pre-pricing) for 2026 (most of it in H1) and expects to mitigate some impact via pricing and cost actions (net drag perhaps ~25–50 bps), while realizing ~ $60 million of year-over-year synergy benefit next year (after delivering $43 million Y/Y in 2025 and exiting 2025 with ~$85 million run-rate savings versus 2024 and a $150 million run-rate target by end‑2027); segment commentary noted Protein Solutions should be at the higher end of revenue growth and Prepared Food & Beverage at the lower end, with margin progression in both segments (slightly stronger improvement in Prepared Foods), and Q1 2026 was guided to $920–$940 million revenue with 14%–15% adjusted EBITDA margin.JBT Marel Financial Statement Overview
Summary
Income Statement
52
Neutral
Balance Sheet
74
Positive
Cash Flow
63
Positive
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 3.80B | 1.72B | 1.66B | 1.59B | 1.40B |
| Gross Profit | 1.33B | 626.50M | 585.70M | 529.40M | 482.10M |
| EBITDA | 301.60M | 204.20M | 268.70M | 212.50M | 202.80M |
| Net Income | -50.50M | 85.40M | 582.60M | 137.40M | 119.10M |
Balance Sheet | |||||
| Total Assets | 8.20B | 3.41B | 2.71B | 2.64B | 2.14B |
| Cash, Cash Equivalents and Short-Term Investments | 186.50M | 1.23B | 483.30M | 71.70M | 78.80M |
| Total Debt | 1.88B | 1.25B | 646.40M | 977.90M | 674.40M |
| Total Liabilities | 3.73B | 1.87B | 1.22B | 1.74B | 1.39B |
| Stockholders Equity | 4.46B | 1.54B | 1.49B | 905.40M | 750.20M |
Cash Flow | |||||
| Free Cash Flow | 238.10M | 195.70M | -15.50M | 57.70M | 172.10M |
| Operating Cash Flow | 341.70M | 233.60M | 39.60M | 142.30M | 223.80M |
| Investing Cash Flow | -1.84B | -41.30M | 725.90M | -416.10M | -272.90M |
| Financing Cash Flow | 458.10M | 561.80M | -354.10M | 270.60M | 80.80M |
JBT Marel Technical Analysis
Neutral
128.55
Price Trends
146.12
Negative
147.73
Negative
141.67
Negative
Market Momentum
-4.87
Negative
41.79
Neutral
63.80
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JBTM, the sentiment is Neutral. The current price of 128.55 is above the 20-day moving average (MA) of 128.22, below the 50-day MA of 146.12, and below the 200-day MA of 141.67, indicating a neutral trend. The MACD of -4.87 indicates Negative momentum. The RSI at 41.79 is Neutral, neither overbought nor oversold. The STOCH value of 63.80 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JBTM.
JBT Marel Risk Analysis
JBT Marel disclosed 45 risk factors in its most recent earnings report. JBT Marel reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
JBT Marel Peers Comparison
UnderperformOutperform
Sector (63)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | $10.77B | 30.59 | 13.29% | ― | 12.60% | 24.02% | |
69 Neutral | $6.47B | 22.36 | 7.69% | ― | -0.75% | 9.22% | |
66 Neutral | $10.74B | 26.05 | 15.81% | 1.17% | 3.19% | 69.89% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | $4.83B | 187.00 | 1.73% | ― | 7.81% | ― | |
58 Neutral | $6.68B | -155.15 | -1.16% | 0.26% | 91.98% | -141.14% | |
53 Neutral | $6.75B | -28.04 | -8.50% | ― | 0.27% | -159.24% |
* Industrials Sector Average
JBTM
JBT Marel
128.55
32.32
33.59%
FLS
Flowserve
84.38
42.47
101.33%
SPXC
SPX
215.97
85.02
64.93%
MIDD
The Middleby
143.03
11.12
8.43%
GTES
Gates Industrial
25.48
8.10
46.61%
MIR
Mirion Technologies
19.27
5.57
40.66%
JBT Marel Corporate Events
Business Operations and StrategyFinancial Disclosures
JBT Marel Highlights Growth Strategy at Investor Day
Positive
Mar 26, 2026
On March 26, 2026, JBT Marel held an Investor Day in New York City, presenting its strategic priorities, financial profile, and integration plans to investors and market professionals. The event highlighted management’s focus on leveraging i...
Business Operations and StrategyFinancial DisclosuresM&A Transactions
JBT Marel Implements New Segment Reporting After Integration
Positive
Feb 18, 2026
On February 18, 2026, JBT Marel said that a previously announced realignment of its reportable segments took effect for the fourth quarter of 2025, following its January 2, 2025 acquisition of Marel hf., consolidating legacy JBT and Marel operatio...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.